Delivery Order SPE2DB20D1109-SPE2DB23FP69E

Award Date 8/8/23
Potential Completion Date 8/9/23
Potential Value $23K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has a ceiling value of $19,473.50 and an ultimate completion date of December 20, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business category....
This federal contract award is for the delivery of Rinvoq ER 45 mg tablets to the Defense Logistics Agency (DLA). The $29,975.83 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The award has an ultimate completion date of October 30, 2023 and was not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for $11,541.19. The contract has an ultimate completion date of May 2, 2023 and is a firm-fixed-price delivery order. There is no set-aside designation for this award. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a firm fixed price of $7,593.71 and an ultimate completion date of December 20, 2023. The contract is a delivery order, which is a type of indefinite delivery contract vehicle. This contract is not designated as a...
This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $24,780.28, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is March 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier to various government agencies,...
This federal contract award is for the delivery of a specific pharmaceutical product, Rinvoq ER 15 mg tablets, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,585.33 and a completion date of September 1, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $19,915.85 and an ultimate completion date of January 4, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation....
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $13,572.92 for the pharmaceutical product Rinvoq ER 15 mg Tablet. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA). The $10,495.14 firm fixed-price delivery order has a completion date of June 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,491.18, is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which does business as...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB23FP69E
    Delivery Order

This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $23,003.57, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract has an ultimate completion date of August 9, 2023 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veteran healthcare programs worldwide. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.

Generated 2/27/25, 10:33 AM